State
of New York
|
1-10113
|
11-0853640
|
(State
of Other Jurisdiction of Incorporation)
|
Commission
File Number)
|
((I.R.S.
Employer Identification Number)
|
o |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
o |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17CFR
240.14a-12)
|
o |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17CFR240.14d-2(b))
|
o |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR
240.13e-4(c))
|
Exhibit
Number
|
Description
|
99.1
|
Press
Release dated August
9, 2007
Announcing Financial Results for the Second Quarter of
2007
|
ACURA PHARMACEUTICALS, INC. | ||
|
|
|
By: | /s/ Peter A. Clemens | |
Peter
A. Clemens
Senior
Vice President & Chief Financial Officer
|
||
Exhibit
Number
|
Description
|
99.1
|
Press
Release dated August
9, 2007
Announcing Financial Results for the Second Quarter of
2007
|